DaVita Clinical Research (DCR) acts as the bridge between DaVita services and the pharmaceutical and biotech research community. Established in 1994, it provides comprehensive multi-specialty (Phase II-III) clinical trial services to the pharmaceutical and biotech industry. DCR has an extensive track record, having conducted more than 500 clinical trials with over 175 pharmaceutical companies. Based in the United States, DCR's focus on Biotechnology and Healthcare contributes to its significance in the industry. While the organization's commitment to aiding scientists and doctors in finding cures is substantial, they rely on collaborative support to further their impact. Currently, there is no information available regarding recent investments or involved investors.
There is no investment information
No recent news or press coverage available for DaVita Clinical Research.
We care about your data, and we'd love to use cookies make your experience better.
